Christophe Melon

2.2k citations

46 papers · 1.8k indexed · h-index 24

Impact in

Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neural Engineering
Neurology top 2%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments

Papers in ⓘ

Cellular and Molecular Neuroscience 36
- Neuroscience and Neuropharmacology Research 20
- Neurotransmitter Receptor Influence on Behavior 12
- Genetic Neurodegenerative Diseases 5
- Neuroscience and Neural Engineering 4
Neurology 22
- Neurological disorders and treatments 17
- Parkinson's Disease Mechanisms and Treatments 16
- Transcranial Magnetic Stimulation Studies 4

Co-authors: Lydia Kerkerian‐Le Goff (27 shared papers)Pascal Salin (18 shared papers)Alain P. Gobert (5 shared papers)Laetitia Cistarelli (5 shared papers)Mark J. Millan (6 shared papers)Jean‐Michel Rivet (3 shared papers)Jean De Vry (3 shared papers)Robert D. Schreiber (2 shared papers)
Journals: Journal of Neurochemistry (6 papers)Neurobiology of Disease (4 papers)European Journal of Neuroscience (3 papers)Journal of Neuroscience (3 papers)European Journal of Pharmacology (2 papers)
Partner nations: France United States Italy

In The Last Decade

Christophe Melon

45 papers receiving 1.8k citations

Peers

Countries citing papers authored by Christophe Melon

Since Specialization

Citations

This map shows the geographic impact of Christophe Melon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Melon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Melon more than expected).

Fields of papers citing papers by Christophe Melon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Melon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Melon. The network helps show where Christophe Melon may publish in the future.

Co-authors

The 25 scholars most cited alongside Christophe Melon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christophe Melon Line = papers co-authored together Christophe Melon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat Synapse ·Alain P. Gobert, Jean‐Michel Rivet, F. Lejeune, Adrian Newman‐Tancredi, Agnès Adhumeau-Auclair, Jean‐Paul Nicolas, Laetitia Cistarelli, Christophe Melon, Mark J. Millan	2000	271
2	Chronic l‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease European Journal of Neuroscience ·Sandra Robelet, Christophe Melon, Benjamin Guillet, Pascal Salin, Lydia Kerkerian‐Le Goff	2004	122
3	Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of α2-adrenergic receptors underlie its actions Neuroscience ·Alain P. Gobert, Jean‐Michel Rivet, Laetitia Cistarelli, Christophe Melon, Mark J. Millan	1999	92
4	α₂‐Adrenergic Receptor Blockade Markedly Potentiates Duloxetine‐ and Fluoxetine‐Induced Increases in Noradrenaline, Dopamine, and Serotonin Levels in the Frontal Cortex of Freely Moving Rats Journal of Neurochemistry ·Alain P. Gobert, Jean‐Michel Rivet, Laetitia Cistarelli, Christophe Melon, Mark J. Millan	1997	85
5	5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat European Neuropsychopharmacology ·Jean De Vry, Robert D. Schreiber, Christophe Melon, M. Dalmus, K.R. Jentzsch	2004	75
6	The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test Psychopharmacology ·Robert D. Schreiber, Christophe Melon, Jean De Vry	1998	75
7	Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia Neuropharmacology ·Khaled-Ezaheir Bennouar, Michelle A. Uberti, Christophe Melon, Maria D. Bacolod, Hermogenes N. Jimenez, Manuel Cajina, Lydia Kerkerian‐Le Goff, Darı́o Doller, Paolo Gubellini	2012	72
8	Chronic high‐frequency stimulation of the subthalamic nucleus and L‐DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission European Journal of Neuroscience ·Paolo Gubellini, Alexandre Eusébio, Abid Oueslati, Christophe Melon, Lydia Kerkerian‐Le Goff, Pascal Salin	2006	70
9	Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation Molecular and Cellular Neuroscience ·Elsa Gouix, Frédéric Léveillé, Olivier Nicole, Christophe Melon, Laurence Had‐Aissouni, Alain Buisson	2009	65
10	Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment Journal of Neurochemistry ·Dario Cuomo, Giuseppina Martella, E. Barabino, Paola Platania, Daniela De Vita, Graziella Madeo, Chelliah Selvam, Cyril Goudet, Nadia Oueslati, Jean‐Philippe Pin, Francine Acher, Antonio Pisani, Corinne Beurrier, Christophe Melon, Lydia Kerkerian‐Le Goff, Paolo Gubellini	2009	61
11	High-Frequency Stimulation of the Subthalamic Nucleus Potentiates l-DOPA-Induced Neurochemical Changes in the Striatum in a Rat Model of Parkinson's Disease Journal of Neuroscience ·Abid Oueslati, Véronique Sgambato, Christophe Melon, Philippe Kachidian, Paolo Gubellini, Mohamed Amri, Lydia Kerkerian‐Le Goff, Pascal Salin	2007	54
12	Chronic fornix deep brain stimulation in a transgenic Alzheimer’s rat model reduces amyloid burden, inflammation, and neuronal loss Brain Structure and Function ·Aurélie Leplus, Inger Lauritzen, Christophe Melon, Lydia Kerkerian‐Le Goff, Denys Fontaine, Frédéric Checler	2018	52
13	Spatial learning, monoamines and oxidative stress in rats exposed to 900 MHz electromagnetic field in combination with iron overload Behavioural Brain Research ·Karima Maâroufi, Laurence Had‐Aissouni, Christophe Melon, Mohsen Sakly, Hafedh Abdelmelek, Bruno Poucet, Étienne Save	2013	52
14	Deep Brain Stimulation of the Center Median-Parafascicular Complex of the Thalamus Has Efficient Anti-Parkinsonian Action Associated with Widespread Cellular Responses in the Basal Ganglia Network in a Rat Model of Parkinson's Disease Journal of Neuroscience ·Loreline Jouve, Pascal Salin, Christophe Melon, Lydia Kerkerian‐Le Goff	2010	49
15	Inhibition of the Mitochondrial Glutamate Carrier SLC25A22 in Astrocytes Leads to Intracellular Glutamate Accumulation Frontiers in Cellular Neuroscience ·Emmanuelle Goubert, Yanina Mircheva, Francesco M. Lasorsa, Christophe Melon, Emanuela Profilo, Julie Sutera, Hélène Becq, Ferdinando Palmieri, Luigi Palmieri, Laurent Aniksztejn, Florence Molinari	2017	45
16	Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra Neurobiology of Disease ·Maxime Assous, Laurence Had‐Aissouni, Paolo Gubellini, Christophe Melon, Imane Nafia, Pascal Salin, Lydia Kerkerian‐Le Goff, Philippe Kachidian	2014	39
17	WAY 100,635 enhances both the `antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex European Journal of Pharmacology ·Mark J. Millan, Mauricette Brocco, Sylvie Veiga, Laetitia Cistarelli, Christophe Melon, Alain P. Gobert	1998	35
18	Portable microstimulator for chronic deep brain stimulation in freely moving rats Journal of Neuroscience Methods ·Claude Forni, O. Mainard, Christophe Melon, D. Goguenheim, Lydia Kerkerian‐Le Goff, Pascal Salin	2012	33
19	Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction Journal of Neurochemistry ·Imane Nafia, Diane B. Ré, F. Masmejean, Christophe Melon, Philippe Kachidian, Lydia Kerkerian‐Le Goff, André Nieoullon, Laurence Had‐Aissouni	2007	32
20	S-16924, a Novel, Potential Antipsychotic with Marked Serotonin1A Agonist Properties. IV. A Drug Discrimination Comparison with Clozapine Journal of Pharmacology and Experimental Therapeutics ·Mark J. Millan, Rudy Schreiber, S. Monneyron, B. Denorme, Christophe Melon, Sophie Queriaux, Anne Dekeyne	1999	32

About Christophe Melon

Christophe Melon is a scholar working on Cellular and Molecular Neuroscience, Neurology, Developmental Neuroscience, Neurology and Pharmacology, having authored 46 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (20 papers), Neurological disorders and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (16 papers), Neurotransmitter Receptor Influence on Behavior (12 papers), Receptor Mechanisms and Signaling (6 papers), Genetic Neurodegenerative Diseases (5 papers), Transcranial Magnetic Stimulation Studies (4 papers) and Neuroscience and Neural Engineering (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.3k citations), Neurology (571 citations), Biological Psychiatry (82 citations), Behavioral Neuroscience (71 citations) and Neurology (149 citations). Christophe Melon has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Lydia Kerkerian‐Le Goff, Pascal Salin, Alain P. Gobert, Laetitia Cistarelli, Mark J. Millan, Jean‐Michel Rivet, Jean De Vry, Robert D. Schreiber, Paolo Gubellini and Adrian Newman‐Tancredi. Their work appears in journals such as Journal of Neurochemistry, Neurobiology of Disease, European Journal of Neuroscience, Journal of Neuroscience and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact